4.7 Review

The schizophrenic faces of PICK1

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 27, Issue 11, Pages 574-579

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2006.09.007

Keywords

-

Funding

  1. MRC [G9629038] Funding Source: UKRI
  2. Medical Research Council [G9629038] Funding Source: researchfish
  3. Medical Research Council [G9629038] Funding Source: Medline
  4. Wellcome Trust [059917] Funding Source: Medline

Ask authors/readers for more resources

Schizophrenia is a grave psychiatric disorder with psychotic symptoms and an enigmatic etiology. Family studies have strongly indicated that genetic risk factors have a role in this disease. Recent findings, together with previously established evidence, highlight the PDZ-domain-containing protein interacting with C-kinase 1 (PICK1) as a promising candidate for a schizophrenia susceptibility gene. Here, we outline possible molecular mechanisms, discuss clinical case-studies that indicate an unexpected role of PICK1 in schizophrenia and discuss potential avenues for pharmacological manipulation of PICK1.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available